高级检索
当前位置: 首页 > 详情页

S100A7 promotes endometrial carcinoma progression by activating the MAPK signaling pathway

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ, Dept Canc Radiotherapy, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China [2]Lishui Peoples Hosp, Dept Tumor Radiotherapy & Chemotherapy, Lishui 323000, Zhejiang, Peoples R China
出处:
ISSN:

关键词: Endometrial carcinoma Proliferation Apoptosis Migration Invasion Angiogenesis

摘要:
S100 calcium binding protein A7 (S100A7) has been proofed to play a carcinogenic role in several cancers. However, its role and the regulatory mechanism in Endometrial carcinoma (EC) was unknown. Western blot was applied to determine the expression of S100A7 and Mitogen-activated protein kinase (MAPK) pathway-related protein in EC cells. Functional in vitro experiments were conducted to explore the effects of S100A7 on cell proliferation, apoptosis, migration, invasion and angiogenesis in EC. As a result, S100A7 expression was dramatically up-regulated in EC cells. Overexpression of S100A7 enhanced EC cells proliferation, migration, invasion and angiogenesis, and suppressed cell apoptosis, as well as activated MAPK signaling pathway. Whereas, knockdown of S100A7 exerted the opposite effects. Our finding suggested that S100A7 may promote the malignant progression of EC by activating MAPK pathway, implying S100A7 has significant potential to be used as an emerging therapeutic target for EC treatment.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 4 区 医学
小类 | 4 区 妇产科学 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 妇产科学 4 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q4 OBSTETRICS & GYNECOLOGY Q4 ONCOLOGY
最新[2023]版:
Q4 OBSTETRICS & GYNECOLOGY Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Hebei Univ, Dept Canc Radiotherapy, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号